Recurrence of Esophageal Intestinal Metaplasia After Endoscopic Mucosal Resection and Radiofrequency Ablation of Barrett's Esophagus: Results From a US Multicenter Consortium

被引:172
|
作者
Gupta, Milli [1 ]
Iyer, Prasad G. [1 ]
Lutzke, Lori [1 ]
Gorospe, Emmanuel C. [1 ]
Abrams, Julian A. [2 ]
Falk, Gary W. [3 ]
Ginsberg, Gregory G. [3 ]
Rustgi, Anil K. [3 ]
Lightdale, Charles J. [2 ]
Wang, Timothy C. [2 ]
Fudman, David I. [2 ]
Poneros, John M. [2 ]
Wang, Kenneth K. [1 ]
机构
[1] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
[2] Columbia Univ, Med Ctr, Div Digest & Liver Dis, New York, NY USA
[3] Univ Penn, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Esophageal Cancer; Prevention; Endoscopic Therapy; EAC; HIGH-GRADE DYSPLASIA; FOCAL ABLATION; EARLY NEOPLASIA; ERADICATION; ADENOCARCINOMA; SURVEILLANCE; REGISTRY;
D O I
10.1053/j.gastro.2013.03.008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND & AIMS: Radiofrequency ablation (RFA) is an established treatment for dysplastic Barrett's esophagus (BE). Although short-term end points of ablation have been ascertained, there have been concerns about recurrence of intestinal metaplasia (IM) after ablation. We aimed to estimate the incidence and identify factors that predicted the recurrence of IM after successful RFA. METHODS: We analyzed data from 592 patients with BE treated with RFA from 2003 through 2011 at 3 tertiary referral centers. Complete remission of intestinal metaplasia (CRIM) was defined as eradication of IM (in esophageal and gastroesophageal junction biopsy specimens), documented by 2 consecutive endoscopies. Recurrence was defined as the presence of IM or dysplasia after CRIM in surveillance biopsies. Two experienced gastrointestinal pathologists confirmed pathology findings. RESULTS: Based on histology analysis, before RFA, 71% of patients had high-grade dysplasia or esophageal adenocarcinoma, 15% had low-grade dysplasia, and 14% had nondysplastic BE. Of patients treated, 448 (76%) were assessed after RFA. Fifty-five percent of patients underwent endoscopic mucosal resection before RFA. The median time to CRIM was 22 months, with 56% of patients in CRIM by 24 months. Increasing age and length of BE segment were associated with longer times to CRIM. Twenty-four months after CRIM, the incidence of recurrence was 33%; 22% of all recurrences observed were dysplastic BE. There were no demographic or endoscopic factors associated with recurrence. Complications developed in 6.5% of subjects treated with RFA; strictures were the most common complication. CONCLUSIONS: Of patients with BE treated by RFA, 56% were in complete remission after 24 months. However, 33% of these patients had disease recurrence within the next 2 years. Most recurrences were nondysplastic and endoscopically manageable, but continued surveillance after RFA is essential.
引用
收藏
页码:79 / +
页数:9
相关论文
共 50 条
  • [21] Endoscopic Mucosal Resection of Barrett's Esophagus and Early Esophageal Cancer
    Peters, Jeffrey H.
    Watson, Thomas A.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (08) : 1299 - 1302
  • [22] Endoscopic Mucosal Resection of Barrett’s Esophagus and Early Esophageal Cancer
    Jeffrey H. Peters
    Thomas A. Watson
    Journal of Gastrointestinal Surgery, 2011, 15
  • [23] NUMBER OF SESSIONS TO ACHIEVE COMPLETE ERADICATION OF INTESTINAL METAPLASIA (CE-IM) PREDICTS RECURRENCE IN BARRETT'S ESOPHAGUS (BE) PATIENTS UNDERGOING ENDOSCOPIC ERADICATION THERAPY (EET): RESULTS FROM THE TREATMENT WITH RESECTION AND ENDOSCOPIC ABLATION TECHNIQUES FOR BARRETT'S ESOPHAGUS (TREAT-BE) CONSORTIUM
    Wani, Sachin B.
    Han, Samuel
    Kushnir, Vladimir
    Early, Dayna
    Mullady, Daniel
    Hammad, Hazem T.
    Brauer, Brian C.
    Thaker, Adarsh M.
    Simon, Violette C.
    Ezekwe, Ezenwanyi
    Hollander, Thomas
    Rastogi, Amit
    Edmundowicz, Steven A.
    Muthusamy, V. Raman
    Komanduri, Sri
    GASTROENTEROLOGY, 2019, 156 (06) : S104 - S105
  • [24] Hemoperitoneum after endoscopic mucosal resection for Barrett's esophagus
    Mercky, Pascale
    Gonzalez, Jean-Michel
    Caillol, Fabrice
    Bories, Erwan
    Pesenti, Christian
    Giovannini, Marc
    ENDOSCOPY, 2014, 46 : E15 - E15
  • [25] Outcomes Associated With Endoscopic Mucosal Resection After Previous Endoscopic Ablation Therapy for Barrett's Esophagus
    Cangemi, David J.
    Qumseya, Bashar
    Rizk, Cynthia
    Raimondo, Massimo
    Woodward, Timothy A.
    Wallace, Michael B.
    Wolfsen, Herbert C.
    GASTROINTESTINAL ENDOSCOPY, 2012, 75 (04) : 507 - 507
  • [26] WHEN SHOULD WE LOOK FOR RECURRENCE FOLLOWING COMPLETE ERADICATION OF INTESTINAL METAPLASIA (CE-IM)? RESULTS FROM THE TREATMENT WITH RESECTION AND ENDOSCOPIC ABLATION TECHNIQUES FOR BARRETT'S ESOPHAGUS (TREAT-BE) CONSORTIUM
    Wani, Sachin B.
    Han, Samuel
    Kushnir, Vladimir
    Early, Dayna
    Mullady, Daniel
    Hammad, Hazem T.
    Brauer, Brian C.
    Thaker, Adarsh M.
    Simon, Violette C.
    Ezekwe, Ezenwanyi
    Hollander, Thomas
    Rastogi, Amit
    Edmundowicz, Steven A.
    Muthusamy, V. Raman
    Komanduri, Sri
    GASTROENTEROLOGY, 2019, 156 (06) : S223 - S223
  • [27] Factors Associated With Recurrence of Barrett's Esophagus After Radiofrequency Ablation
    Tan, Mimi C.
    Kanthasamy, Kavin A.
    Yeh, Allison G.
    Kil, Daniel
    Pompeii, Lisa
    Yu, Xiaoying
    El-Serag, Hashem B.
    Thrift, Aaron P.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (01) : 65 - +
  • [28] Rates of Recurrence and Achievement of a Second Complete Eradication of Intestinal Metaplasia in Patients Treated With Radiofrequency Ablation for Barrett's Esophagus
    Wolf, W. Asher
    Cotton, Cary C.
    Eluri, Swathi
    Triadafilopoulos, George
    Runge, Thomas
    Wolfsen, Herbert C.
    Li, Nan
    Komanduri, Srinadh
    Chmielewski, Gary W.
    Ertan, Atilla
    Dellon, Evan S.
    Shaheen, Nicholas J.
    GASTROENTEROLOGY, 2015, 148 (04) : S139 - S139
  • [29] Impact of Complete Eradication of Intestinal Metaplasia (CEIM) Definition on Recurrence of Barrett's Esophagus After Successful Endoscopic Therapy: Results From an International, Multi-Center Consortium
    Krishnamoorthi, Rajesh
    Thiagarajan, Varun K.
    Vennelaganti, Sreekar
    Repici, Alessandro
    Konda, Vani J.
    Waxman, Irving
    Seewald, Stefan
    Stier, Matthew W.
    Haidry, Rehan
    Buckles, Daniel
    Gupta, Neil
    Bansal, Ajay
    Mathur, Sharad
    Olyaee, Mojtaba S.
    Bourke, Michael J.
    Falk, Gary W.
    Nguyen, Julie
    Jegadeesan, Ramprasad
    Vennalaganti, Prashanth
    Vittal, Anusha
    Kennedy, Kevin F.
    Sharma, Prateek
    Ross, Andrew S.
    GASTROINTESTINAL ENDOSCOPY, 2017, 85 (05) : AB157 - AB158
  • [30] Radiofrequency Ablation and Endoscopic Mucosal Resection for Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma: Outcomes of the UK National Halo RFA Registry
    Haidry, Rehan J.
    Dunn, Jason M.
    Butt, Mohammed A.
    Burnell, Matthew G.
    Gupta, Abhinav
    Green, Sarah
    Miah, Haroon
    Smart, Howard L.
    Bhandari, Pradeep
    Smith, Lesley Ann
    Willert, Robert
    Fullarton, Grant
    Morris, John
    Di Pietro, Massimo
    Gordon, Charles
    Penman, Ian
    Barr, Hugh
    Patel, Praful
    Boger, Philip
    Kapoor, Neel
    Mahon, Brinder
    Hoare, Jonathon
    Narayanasamy, Ravi
    O'Toole, Dermot
    Cheong, Edward
    Direkze, Natalie C.
    Ang, Yeng
    Novelli, Marco
    Banks, Matthew R.
    Lovat, Laurence Bruce
    GASTROENTEROLOGY, 2013, 145 (01) : 87 - 95